| 17423-5 |
Parvovirus B19 Ab.IgM |
ACnc |
Ser |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Parvovirus B19 IgM Ab [Presence] in Serum |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
17423-5 |
|
|
|
|
|
|
|
|
0 |
Deprecated B19V IgM Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B19 virus; B19V; Fifth Disease; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Parvo; Parvo virus; Parvov; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 17424-3 |
1,4-Dichlorobenzene |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
1,4-Dichlorobenzene [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
17424-3 |
|
|
|
|
Observation |
|
|
|
0 |
1,4DCB Bld-mCnc |
|
|
|
Y |
|
1,4DCB; 3,3'-dichlorobenzidine; Blood; C6H4Cl2; DCB; Dichloricide; Dichlorocide; DRUG/TOXICOLOGY; Drugs; Evola; Globol; i; Level; Mass concentration; Para; Para dichlorobenzene; Paracide; Paradow; Paramoth; Paranuggets; Para-zene; p-chlorophenyl chloride; PDB; PDCB; p-DCB; p-dichlorobenzene; p-dichlorobenzol; Persia-perazol; Point in time; QNT; Quan; Quant; Quantitative; Random; Santochlor; WB; Whole blood |
2.73 |
1.0l |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 17426-8 |
Penicillium roqueforti Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Penicillium roqueforti IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
17426-8 |
|
|
|
|
Both |
|
|
|
0 |
P roqueforte IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Farmers lung; Immune globulin E; Immunoglobulin E; m30; P roqueforte; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.42 |
1.0l |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 17427-6 |
Penicillium sp Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Penicillium sp Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
17427-6 |
|
|
|
|
Both |
|
|
|
0 |
Penicillium Ab Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Gm27; m27; Penicillium spp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 17428-4 |
Pentacarboxylporphyrins |
MRat |
Stool |
24H |
Qn |
|
|
ACTIVE |
Pentacarboxylporphyrins [Mass/time] in 24 hour Stool |
|
MIN |
DefinitionDescription |
|
|
ug/24 H |
|
|
|
|
|
|
CHEM |
|
17428-4 |
|
|
|
|
Observation |
|
|
|
0 |
Penta-CP 24h Stl-mRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Mass Rate; mRate; Pentacarboxyl porphyrins; Pentacarboxyporhyrin; Penta-CP; Pentaporphyrins; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/(24.h) |
|
|
|
0 |
| 17429-2 |
Pentachlorophenol |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Pentachlorophenol [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
17429-2 |
|
|
|
|
Both |
|
|
|
0 |
Pentachlorophen Bld-mCnc |
|
|
|
Y |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; PCP; Penta; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 1743-4 |
Alanine aminotransferase |
CCnc |
Ser/Plas |
Pt |
Qn |
With P-5'-P |
|
ACTIVE |
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
1743-4 |
|
With P-5'-P |
|
|
Both |
|
|
|
0 |
ALT SerPl w P-5'-P-cCnc |
|
|
|
Y |
|
Ala; Alanine transaminase; ALAT; Alpha alanine; ALT; Catalytic Concentration; Chemistry; Glutamic-pyruvic transferase; Hepatology; L-alanine; Liver; P prime; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SGPT; SR; w P-5'-P |
2.73 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
| 17430-0 |
Pentane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Pentane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
17430-0 |
|
|
|
|
Both |
|
|
|
0 |
Pentane Bld-mCnc |
|
|
|
Y |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 17431-8 |
PENTobarbital |
MCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
PENTobarbital [Mass/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
17431-8 |
|
|
|
|
Both |
|
|
|
0 |
Pentobarb Gast-mCnc |
|
|
|
Y |
|
Addiction; Barbiturate; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Level; Mass concentration; Nembutal; Pentobarb; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 17432-6 |
Tetrachloroethylene |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Tetrachloroethylene [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
17432-6 |
|
|
|
|
Both |
|
|
|
0 |
TTCE SerPl-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Perchloroethylene; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tetrachloroethene; TTCE |
2.42 |
1.0l |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 17433-4 |
pH |
LsCnc |
XXX |
Pt |
SemiQn |
|
|
ACTIVE |
pH of Specimen |
|
MAJ |
DefinitionDescription |
|
|
pH |
|
|
|
|
|
|
CHEM |
|
17433-4 |
|
|
|
|
Both |
|
|
|
0 |
pH Spec |
|
|
|
|
|
Chemistry; Log molar concentration; Misc; Miscellaneous; Other; Point in time; Random; SmQn; Spec; To be specified in another part of the message; Unspecified |
2.75 |
1.0l |
|
|
|
|
|
|
|
[pH] |
|
|
|
0 |
| 17434-2 |
Phenazopyridine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Phenazopyridine [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
17434-2 |
|
|
|
|
Both |
|
|
|
0 |
Phenazopyridine SerPl-mCnc |
|
|
|
Y |
|
3-(phenoazo)-2,6-pyradinediamine; C11H11N5; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pyridium; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 17435-9 |
Pheniramine |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Pheniramine [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
17435-9 |
|
|
|
|
Both |
|
|
|
0 |
Pheniramine Ur-mCnc |
|
|
|
Y |
|
Avil; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; Prophenpyridamine; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 17436-7 |
PHENobarbital |
MCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
PHENobarbital [Mass/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
17436-7 |
|
|
|
|
Both |
|
|
|
0 |
Phenobarb Gast-mCnc |
|
|
|
Y |
|
Barbiturate; c417; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Luminal; Mass concentration; Nirvonal; PHBR; Phenobarb; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 17437-5 |
Phenolphthalein |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Phenolphthalein [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
17437-5 |
|
|
|
|
Both |
|
|
|
0 |
Phenolphthalein Ur-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phenolthalein; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 17438-3 |
Phenolphthalein |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Phenolphthalein [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
17438-3 |
|
|
|
|
Both |
|
|
|
0 |
Phenolphthalein Bld-mCnc |
|
|
|
Y |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phenolthalein; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 17439-1 |
Phenols |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Phenols [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
17439-1 |
|
|
|
|
Both |
|
|
|
0 |
Phenols Bld-mCnc |
|
|
|
Y |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phenol + p-cresol + o-cresol + m-cresol; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.42 |
1.0l |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 1744-2 |
Alanine aminotransferase |
CCnc |
Ser/Plas |
Pt |
Qn |
No addition of P-5'-P |
|
ACTIVE |
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
1744-2 |
|
No addition of P-5'-P |
|
|
Both |
|
|
|
0 |
ALT SerPl w/o P-5'-P-cCnc |
|
|
|
Y |
|
Ala; Alanine transaminase; ALAT; Alpha alanine; ALT; Catalytic Concentration; Chemistry; Glutamic-pyruvic transferase; Hepatology; L-alanine; Liver; P prime; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SGPT; SR; w/o P-5'-P |
2.73 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
Changed Method from 'Without P-5'-P' to 'No addition of P-5'-P' to clarify that no additional P-5'-P is added when running this test, but that any naturally occurring P-5'-P that was already in the patient's serum is not removed. |
0 |
| 17440-9 |
Phenothiazines |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Phenothiazines [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
17440-9 |
|
|
|
|
Both |
|
|
|
0 |
Phenothiaz SerPl-aCnc |
|
|
|
Y |
|
Arbitrary concentration; Dibenzothiazine; DRUG/TOXICOLOGY; Drugs; Phenothiaz; Phenothiazine; Phenothiazn; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.69 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 17441-7 |
Phenothiazines |
ACnc |
Urine |
Pt |
Qn |
|
|
DISCOURAGED |
Phenothiazines [Units/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
17441-7 |
|
|
|
|
Both |
|
|
|
0 |
Phenothiaz Ur-aCnc |
|
|
|
Y |
|
Arbitrary concentration; Dibenzothiazine; DRUG/TOXICOLOGY; Drugs; Phenothiaz; Phenothiazine; Phenothiazn; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.69 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 17442-5 |
Phenylephrine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Phenylephrine [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
17442-5 |
|
|
|
|
Both |
|
|
|
0 |
Phenylephrine SerPl-mCnc |
|
|
|
Y |
|
Anusol; DRUG/TOXICOLOGY; Drugs; Fenox; Gouttes nasales; Level; Mass concentration; M-synephrine; Neo-synephrine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Visopt |
2.73 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 17443-3 |
Phenylpropanolamine |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Phenylpropanolamine [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
17443-3 |
|
|
|
|
Both |
|
|
|
0 |
PPA Ur-mCnc |
|
|
|
Y |
|
Addiction; Dexatrim; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Norephedrine; Norephidrine; Point in time; PotentialForAbuse; PPA; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 17444-1 |
Phenytoin |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Phenytoin [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
17444-1 |
|
|
|
|
Both |
|
|
|
0 |
Phenytoin Ur-mCnc |
|
|
|
Y |
|
DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; DRUG/TOXICOLOGY; Drugs; Epanutin; Fenantoin; Lehydan; Level; Mass concentration; Phenhydan; PHYT; Point in time; QNT; Quan; Quant; Quantitative; Random; Sinergina; UA; UR; Urn; Zentropil |
2.73 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 17445-8 |
Phoma herbarum Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Phoma herbarum IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
17445-8 |
|
|
|
|
Both |
|
|
|
0 |
P herbarum IgG Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; P herbarum; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 17446-6 |
Phoma sp Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Phoma sp IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
17446-6 |
|
|
|
|
Both |
|
|
|
0 |
Phoma IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR |
2.73 |
1.0l |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
